| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Mauro Panteghini | Q56418921 |
| P2093 | author name string | Robert H Christenson | |
| Fred S Apple | |||
| Allan S Jaffe | |||
| Alan H B Wu | |||
| Jan Ravkilde | |||
| Johannes Mair | |||
| Martin Mockel | |||
| Franca Pagani | |||
| Oliver Danne | |||
| Jillian Tate | |||
| Committee on Standardization of Markers of Cardiac Damage of the IFCC | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| acute coronary syndrome | Q266018 | ||
| P304 | page(s) | 810-824 | |
| P577 | publication date | 2005-03-17 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome | |
| P478 | volume | 51 |
| Q36601665 | "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes |
| Q36155188 | A Plaque Disruption Index Identifies Patients with Non-STE-Type 1 Myocardial Infarction within 24 Hours of Troponin Positivity |
| Q47975464 | A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients |
| Q37765287 | A timely diagnosis of myocardial infarction. |
| Q38471899 | Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. |
| Q35842736 | Alterations in the rat serum proteome during liver injury from acetaminophen exposure |
| Q41091522 | Altered Maternal Plasma Glycogen Phosphorylase Isoenzyme BB as a Biomarker for Preeclampsia and Small for Gestational Age. |
| Q35771734 | An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome. |
| Q37265535 | Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis |
| Q38144914 | Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice? |
| Q48115682 | Biomarkers for the prediction of major adverse cardiovascular events in patients with acute coronary syndrome |
| Q37207294 | Biomarkers in Acute Coronary Syndrome |
| Q37994306 | Biomarkers in acute myocardial injury |
| Q36836546 | Biomarkers of cardiovascular damage |
| Q37765286 | Biomarkers of vulnerable plaque: the missing link with ischemia. |
| Q50574609 | Can ischemia-modified albumin be a valuable indicator of tissue ischemia in polycythemia vera? |
| Q92622728 | Cardiac Biomarkers: What Is and What Can Be |
| Q30318331 | Cardiac biomarkers in perioperative medicine : significance for noncardiac surgery patients |
| Q82799617 | Cardiac troponins and chronic kidney disease |
| Q37207281 | Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice |
| Q51744835 | Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat. |
| Q37743322 | Choline and betaine in health and disease |
| Q37705432 | Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability |
| Q35533943 | Combinatorial Determination of Ischemia Modified Albumin and Protein Carbonyl in the Diagnosis of NonST-Elevation Myocardial Infarction |
| Q36645580 | Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies |
| Q50535390 | Correlation between Fc γ R III a and aortic atherosclerotic plaque destabilization in ApoE knockout mice and intervention effects of effective components of chuanxiong rhizome and red peony root. |
| Q47624214 | Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome |
| Q90088381 | Curcumin effects on myeloperoxidase, interleukin-18 and matrix metalloproteinase-9 inflammatory biomarkers in patients with unstable angina: A randomized clinical trial |
| Q33803001 | Current developments in salivary diagnostics. |
| Q37859787 | Current role of myeloperoxidase in routine clinical practice |
| Q80414195 | Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia |
| Q26764769 | Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials |
| Q42333297 | Do We Really Need Another Biomarker to Diagnose Myocardial Infarction After Coronary Artery Bypass Graft Surgery? |
| Q45102946 | Early detection of acute coronary syndromes and risk stratification by multimarker analysis |
| Q40621598 | Effect of supplementation with vitamin E and C on plasma hsCRP level and cobalt-albumin binding score as markers of plasma oxidative stress in obesity. |
| Q37115819 | Emerging families of biomarkers for coronary artery disease: inflammatory mediators |
| Q54351849 | Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation. |
| Q40915092 | Evaluation of Ischemia-Modified Albumin, Malondialdehyde, and Advanced Oxidative Protein Products as Markers of Vascular Injury in Diabetic Nephropathy |
| Q89249260 | Evaluation of Pregnancy-Associated Plasma Protein-A Levels in Patients with Chronic Obstructive Pulmonary Disease and Associations with Disease Severity |
| Q42176446 | Evaluation of ischemia-modified albumin and C-reactive protein in type 2 diabetics with and without ketosis |
| Q51357068 | Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus. |
| Q55091571 | Evolution of proteomic biomarker for chronic liver disease: Promise into reality. |
| Q36686141 | Examination of serum pregnancy-associated plasma protein A clinical value in acute coronary syndrome prediction and monitoring |
| Q42184230 | Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase |
| Q37919535 | Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures |
| Q34390884 | Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations |
| Q90725071 | Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction |
| Q28283661 | Glycogen phosphorylase BB in acute coronary syndromes |
| Q36369470 | Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia |
| Q36629931 | Heart valve tissue engineering: concepts, approaches, progress, and challenges |
| Q83585649 | High positive predictive value of PAPP-A for acute coronary syndrome diagnosis in heparin-naïve patients |
| Q34438850 | High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy |
| Q46737643 | High-workload endurance training may increase serum ischemia-modified albumin concentrations. |
| Q33628912 | Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis |
| Q46880762 | Identification of cardiac repercussions after intense and prolonged concentric isokinetic exercise in young sedentary people. |
| Q36601679 | Identification of myocardial injury in the emergency setting |
| Q82770044 | Impact of LDL-apheresis on inflammation and microcirculation |
| Q54628037 | Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. |
| Q36148595 | Inclusion of biomarkers for detecting perturbations in the heart and lung and lipid/carbohydrate metabolism in National Toxicology Program studies |
| Q47310670 | Increase in matrix metalloproteinases from endothelial cells exposed to umbilical cord plasma from high birth weight newborns |
| Q46090017 | Increased ischaemia modified albumin following coronary artery bypass grafting |
| Q46476433 | Influence of acute physical exercise on emerging muscular biomarkers. |
| Q37071026 | Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care |
| Q45746333 | Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I. |
| Q37810261 | Ischemia modified albumin changes - review and clinical implications |
| Q84590575 | Ischemia-modified albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas |
| Q57913443 | Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain |
| Q58805331 | Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding |
| Q39016250 | Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines |
| Q30402901 | Label-free detection of C-reactive protein using a carbon nanofiber based biosensor |
| Q38606934 | Laboratory medicine in the new healthcare environment. |
| Q81400150 | Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 |
| Q48752708 | Lipoprotein apheresis reduces biomarkers of plaque destabilization and cardiovascular risk. |
| Q48125660 | Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II). |
| Q36970369 | Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease |
| Q55220563 | Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay. |
| Q28219726 | Myocardial infarct and unstable angina pectoris: diagnostics and therapy |
| Q37009466 | New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department |
| Q39986083 | Non-conventional markers of atherosclerosis before and after gastric banding surgery |
| Q33355010 | Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling |
| Q90744103 | Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases |
| Q36120710 | Novel biomarkers for risk stratification and identification of life-threatening cardiovascular disease: troponin and beyond |
| Q28468555 | Overview of Albumin and Its Purification Methods |
| Q37696962 | PAPP-A as a marker of increased long-term risk in patients with chest pain |
| Q38004498 | Paraoxonase 1 in chronic kidney failure |
| Q36807461 | Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties |
| Q84983360 | Placental Growth Factor as Short-Term Predicting Biomarker in Acute Coronary Syndrome Patients with Non-ST Elevation Myocardial Infarction |
| Q57825192 | Placental Growth Factor in Patients with Decreased Renal Function |
| Q37179515 | Plasma endothelin-1 level at the onset of ischemic ventricular fibrillation predicts resuscitation outcome |
| Q55052917 | Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy. |
| Q37207078 | Platelet reactivity and the identification of acute coronary syndromes in the emergency department |
| Q57825165 | Pregnancy-Associated Plasma Protein A as an Independent Mortality Predictor in Long-Term Hemodialysis Patients |
| Q51405047 | Pregnancy-associated plasma protein-A (PAPP-A) as a possible biomarker in patients with coronary artery disease. |
| Q36624223 | Present and future biochemical markers for detection of acute coronary syndrome |
| Q24289043 | Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study |
| Q92837892 | Prognostic significance of ischemia-modified albumin for severe acute pancreatitis |
| Q46733869 | Progress in developing polymerized crystalline colloidal array sensors for point-of-care detection of myocardial ischemia. |
| Q44800910 | Protective role of statins in patients with acute coronary syndrome aged ≥ 75 years with low LDL-C who underwent percutaneous coronary intervention |
| Q36561644 | Protein biomarker discovery and validation: the long and uncertain path to clinical utility |
| Q39684610 | Proteomic analysis of rat plasma following transient focal cerebral ischemia |
| Q36445586 | Proteomics and heart disease: identifying biomarkers of clinical utility |
| Q42912216 | Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing |
| Q43890271 | Quantification of cardiovascular disease biomarkers via functionalized magnetic beads and on-demand detachable quantum dots |
| Q36646180 | Research translation: a new frontier for clinical laboratories |
| Q34530136 | Role of biomarkers in risk stratification of acute coronary syndrome |
| Q39097080 | Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia |
| Q45188174 | Serial analyses of C-reactive protein and myeloperoxidase in acute coronary syndrome. |
| Q43077504 | Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease |
| Q43473309 | Serum myeloperoxidase level predicts reperfusion in patients with myocardial infarction receiving thrombolytic therapy |
| Q37055493 | Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study |
| Q46776961 | Spectroscopic diagnosis of myocardial infarction and heart failure by Fourier transform infrared spectroscopy in serum samples |
| Q54275185 | Standardization of ischemia-modified albumin testing: adjustment for serum albumin. |
| Q49587416 | Stronger correlation with myocardial ischemia of high-sensitivity troponin T than other biomarkers |
| Q40220343 | Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages |
| Q35844023 | Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease |
| Q46498283 | Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP. |
| Q34786630 | The Association between Diabetic Retinopathy and Levels of Ischemia-Modified Albumin, Total Thiol, Total Antioxidant Capacity, and Total Oxidative Stress in Serum and Aqueous Humor |
| Q36306739 | The effect of doubling the statin dose on pro-inflammatory cytokine in patients with triple-vessel coronary artery disease |
| Q43076887 | The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women |
| Q36608835 | The importance of analytical quality specifications for biomarker assays currently used in acute cardiac care. |
| Q34257083 | The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction |
| Q37230702 | The role of proteomics in clinical cardiovascular biomarker discovery. |
| Q36727124 | The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. |
| Q34092815 | Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development |
| Q44204171 | Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study |
| Q46214813 | Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation |
| Q36601693 | Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification? |
| Q79882279 | [Biomarkers in cardiology--state of the art 2007] |
| Q90465612 | miR-639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma |
Search more.